Off-Label Use of Intravenous Immune Globulin (IVIG)
J6 · Effective Nov 1, 2022
5 active Medicare policies list D68.023, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
National · Effective Oct 1, 2026
J6 · Effective Jul 1, 2026
National · Effective Nov 6, 2025
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D68.023 |
|---|---|---|
| Genetic Testing | Feb 27, 2024 | Covered |